Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States

Pediatrics

Volumn 125, Issue 2, 2010, Pages

  Boom, Julie A ^a,b   Tate, Jacqueline E ^c   Sahni, Leila C ^a,c   Rench, Marcia A ^a,b   Hull, Jennifer J ^c   Gentsch, Jon R ^c   Patel, Manish M ^c   Baker, Carol J ^a,b   Parashar, Umesh D ^c  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Diarrhea; Rotavirus; Rotavirus vaccine; Vaccine effectiveness

Indexed keywords

PENTAVALENT ROTAVIRUS VACCINE; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG;

ACUTE GASTROENTERITIS; ARTICLE; BIRTH; CASE CONTROL STUDY; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE REGISTRY; DISEASE SEVERITY; DRUG EFFICACY; FECES ANALYSIS; FEMALE; GROUPS BY AGE; HEALTH CARE PERSONNEL; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRESCHOOL CHILD; PRIORITY JOURNAL; REHYDRATION; RESPIRATORY TRACT INFECTION; ROTAVIRUS; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES; URBAN POPULATION;

AGE DISTRIBUTION; CASE-CONTROL STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; MALE; PRODUCT SURVEILLANCE, POSTMARKETING; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TEXAS; URBAN POPULATION; VACCINES, ATTENUATED;

EID: 76049110309     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-1021     Document Type: Article

References (21)

1. Charles MD, Holman RC, Curns AT, Parashar UD, Glass RI, Bresee JS. Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J. 2006;25(6):489-493
2. Fischer TK, Viboud C, Parashar U, et al. Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis. 2007;195(8):1117-1125
3. Malek MA, Curns AT, Holman RC, et al. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics. 2006;117(6):1887-1892
4. Glass RI, Kilgore PE, Holman RC, et al. The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. J Infect Dis. 1996;174(suppl 1):S5-S11
5. Parashar UD, Holman RC, Clarke MJ, Bresee JS, Glass RI. Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J Infect Dis. 1998;177(1):13-17
6. Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-12):1-13
7. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent humanbovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23-33
8. Clemens J, Brenner R, Rao M, Tafari N, Lowe C. Evaluating new vaccines for developing countries: efficacy or effectiveness? JAMA. 1996;275(5):390 -397
9. Payne DC, Staat MA, Edwards KM, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics. 2008;122(6):1235-1243
10. Das BK, Gentsch JR, Cicirello HG, et al. Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol. 1994;32(7):1820-1822
11. Gentsch JR, Glass RI, Woods P, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol. 1992;30(6):1365-1373
12. Gouvea V, Glass RI, Woods P, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol. 1990;28(2):276-282
13. Griffin DD, Nakagomi T, Hoshino Y, et al. Characterization of nontypeable rotavirus strains from the United States: identification of a new rotavirus reassortant (P2A[6],G12) and rare P3[9] strains related to bovine rotaviruses. Virology. 2002;294(2):256-269
14. Skowronski DM, Masaro C, Kwindt TL, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine. 2007;25(15):2842-2851
15. Orenstein EW, De Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007;36(3):623-631
16. Kelly H, Carville K, Grant K, Jacoby P, Tran T, Barr I. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One. 2009;4(3):e5079
17. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: Wiley; 2000
18. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis. 1990;22(3):259-267
19. Brousseau DC, Hoffmann RG, Nattinger AB, Flores G, Zhang Y, Gorelick M. Quality of primary care and subsequent pediatric emergency department utilization. Pediatrics. 2007;119(6):1131-1138
20. Guttman N, Zimmerman DR, Nelson MS. The many faces of access: reasons for medically nonurgent emergency department visits. J Health Politics Pol Law. 2003;28(6):1089-1120
21. Widdowson MA, Meltzer MI, Zhang X, et al. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics. 2007;119(4):684-697